Numbers

The Numbers

Henkel is a €20.5B-revenue German consumer/industrial hybrid whose Adhesive Technologies arm (52% of sales, the best business in the house) keeps getting repriced with a Consumer Brands arm (47%) that has been margin-weaker and slower-growing. The stock trades at roughly 13x trailing earnings — the cheapest it has been in more than a decade, well under both its own 20-year average (around 20x) and every European/US staples peer except Reckitt. The single metric most likely to rerate this name is Consumer Brands adjusted EBIT margin: FY2025 already printed a 14.8% adjusted group margin, up from 10.4% in FY2022, and another leg would confirm that the 2022–23 earnings trough was cyclical rather than structural.

A. Snapshot

B. Quality scorecard — is this a well-run business that will still be around in 10 years?

Henkel screens as a high-quality balance sheet on a medium-quality business: the safety indicators are investment-grade and the accruals are clean, but the growth line is weak and profitability is a full tier below Procter & Gamble or L'Oréal. Scores are estimated from reported financials.

C. Revenue and earnings power — 20 years

The 2022 print was the real break — inventory-revaluation charges and raw-material pass-through lag slashed operating margin to 8.1%, the lowest since 2009. The rebound to 13.7% in 2025 is nearly all back to the 2012–2019 band; what is still missing is the top-line, which peaked at €22.4B in 2022 and has dropped 9% since on a mix of divestments (Russia, detergent brand sales) and negative FX.

D. Cash generation — are the earnings real?

Five-year CFO/NI averages 131% and FCF/NI 112%, so the earnings convert to cash cleanly on average — but the volatility is real: 2022 printed only €0.65B of FCF against €1.25B of reported profit as working capital unwound through receivables. Capex is a remarkably steady €600-700M, about 3% of sales, which is low for a company with this much manufacturing footprint.

E. Capital allocation

The capital allocation personality has shifted visibly: Henkel was an acquirer through 2017 (Sun Products, Schwarzkopf Professional add-ons, Darex), went quiet during the pandemic, then returned €856M of buybacks in 2025 — the largest repurchase in the company's history outside the one-off €803M program in 2022. The dividend has never been cut in 20 years.

F. Balance-sheet health

Leverage is a non-issue. Net debt of €0.9B against €2.8B of operating profit gives 0.3x coverage, inside the top quartile of investment-grade industrials. Gross debt peaked at €4.5B during 2018–2019 (Adhesive Technologies M&A funding); the company has repaid aggressively since, and 2025 closed with €2.7B of cash against €3.6B of debt.

G. Valuation — now vs its own 20-year history

This is the chart that matters. The 5-year mean P/E is 19.3x, the 16-year mean is 20.0x, and today's multiple is 13.3x — more than 1 standard deviation below both. The only meaningful comparisons to a sub-14x print in the last 16 years are the brief windows in 2011 (euro-crisis panic) and late 2024 (post-Q3 guide-down). The market is paying for this business as if Adhesive Technologies' industrial cyclicality will reset earnings lower — not as if 2025's margin recovery is durable.

H. Peer comparison

Henkel trades near the bottom of this group on P/E and EV/EBIT, yet its operating margin (13.7%) sits mid-pack and its balance sheet is the cleanest of any peer. The only peer cheaper on P/E is Reckitt — and Reckitt is in a well-known formula-litigation and category-recovery mess. The gap that matters: Henkel's EV/EBIT of 9.8x is 40% below the peer median (around 16x). That is the argument for the stock.

I. Fair value and scenario

Base case sits around €85, implying roughly 30% upside from today's €65.48. That is built on a 15x multiple — still a discount to Henkel's own 16-year mean — applied to 2026E EPS that assumes no operating-margin backtracking. A simple EV/EBIT reversion to 13x (two-thirds of the 20-year average) on €2.9B of EBIT would imply an enterprise value of €37.7B and a share price above €90 after netting debt.

Close

The numbers confirm that Henkel's margin reset is real — the adjusted EBIT margin has climbed 440bps in three years, the balance sheet ended 2025 with €2.7B of cash, and buybacks resumed at their largest-ever cadence. The numbers contradict the popular story that Henkel is a "stodgy, no-growth consumer name": half its revenue comes from Adhesive Technologies, a business with structurally higher ROIC and more pricing power than the Consumer Brands half, and the stock has never been as cheap as it is today relative to its own history. The single item to watch in the next twelve months is first-half 2026 Consumer Brands organic sales: if the unit prints even a flat comp, the margin-recovery story completes and the 13x P/E looks indefensible.